Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy

Sponsor
Vanderbilt University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05178992
Collaborator
National Institute on Aging (NIA) (NIH)
200
1
2
45.6
4.4

Study Details

Study Description

Brief Summary

The objective of this study is to demonstrate the impact of a socially assistive robot system on reducing apathy among cognitively impaired older adults residing in long term care facilities. Earlier phases of this project demonstrated the feasibility and acceptability of the robotic system. First, investigators will improve the social robotic interaction architecture through additional software development, enhance its versatility, and make it easy for non-experts to run. Second, 188 participants will be randomized to either usual activity programs at the long term care facility, or the usual activity programs plus the robotic activities. Researchers will examine the effect on apathy and also plan on examining underlying individual and facility factors that influence the impact of the robotic activities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Socially Assistive Robot Activity
Phase 1/Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomized to either Usual Activity Program or Usual Activity Program + Robot Activity within each long term care facility. At each site, the order of the robot type (humanoid or dog) will be randomized. Each participant will participate in two sessions/week for 8 weeks (4 weeks with humanoid robot, 4 weeks with dog robot).Participants will be randomized to either Usual Activity Program or Usual Activity Program + Robot Activity within each long term care facility. At each site, the order of the robot type (humanoid or dog) will be randomized. Each participant will participate in two sessions/week for 8 weeks (4 weeks with humanoid robot, 4 weeks with dog robot).
Masking:
Single (Outcomes Assessor)
Masking Description:
Trained research assistants separate from other research personnel will collect outcomes; these research personnel will be blinded to the hypotheses and group assignments.
Primary Purpose:
Treatment
Official Title:
Impact of a Novel Socially Assistive Robotic Architecture on Engaging Older Adults With Mild Cognitive Impairment, Alzheimer's Disease and Related Dementia in Long Term Care Settings
Actual Study Start Date :
Sep 13, 2021
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Socially Assistive Robot Activity

Participants will attend two sessions per week and interact with the robot. Four weeks with a humanoid robot and four weeks with a dog robot. Participants can continue to join other activities held within the facility.

Behavioral: Socially Assistive Robot Activity
Participants will attend two weekly sessions with robot activities. Each session will last 30 minutes. Participants will attend robot sessions for 8 weeks.

Active Comparator: Usual Activity Program

Participants will attend at least two sessions per week at activities held within the facility. They will not be exposed to the robot activities.

Behavioral: Socially Assistive Robot Activity
Participants will attend two weekly sessions with robot activities. Each session will last 30 minutes. Participants will attend robot sessions for 8 weeks.

Outcome Measures

Primary Outcome Measures

  1. Change in Apathy [Baseline to Week 8]

    Apathy Evaluation Scale - Clinician (AES-C) will be used to assess changes in composite apathy score from baseline, Week 4, and Week 8. The AES-C is a validated 18-item instrument used to assess cognitive, behavioral, emotional and other symptoms of apathy. Clinicians rate each item based on verbal and nonverbal information provided by the participant. Item scores range from 1 (not at all characteristic) to 4 (a lot characteristic). Total scores range from 18 to 72 where higher derived scores indicate greater apathy.

Secondary Outcome Measures

  1. Change in Trail Making Test (TMT) [Baseline to Week 8]

    The TMT is a well established test of executive function and has two forms. TMT-A consists of a series of numbers in circles displayed randomly on a page; the person links the numbers in sequence. TMT-B consists of numbers (1 to 13) and letters (A to L) inside circles randomly placed on a page; the person alternates in connecting ascending numbers with ascending letters. TMT is scored by time in seconds to complete, up to 5 minutes. TMT-A normal time is 29 seconds and deficient score is >78 seconds. TMT-B average score is 75 seconds and deficient score > 273 seconds.

  2. Change in Animal Fluency Test [Baseline to Week 8]

    Verbal fluency tests require verbal ability and executive control processes; the Animal Naming test requires naming 15 animals in 1 minute; thus, less than 15 animals named in 1 minute is considered a deficient score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Residing >3 months in long term care facility

  • Evidence of mild cognitive impairment (SAGE score 15-16), mild dementia (SAGE score <15, AD8<2, DSRD<19), or moderate dementia (SAGE <15, AD8>1, DSRD 19-36)

  • Symptoms of apathy (Score 30+ on AES-C)

Exclusion Criteria:
  • Severe cognitive impairment

  • Physically unable to participate

  • Unable to provide assent

  • Uncorrected vision or hearing

  • Never spoke English

  • Unable to sit comfortably in chair

  • Acutely ill, terminally ill or unresponsive

  • Unable to be moved to activity location

  • Aggressive or combative

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vanderbilt University Nashville Tennessee United States 37212-2010

Sponsors and Collaborators

  • Vanderbilt University
  • National Institute on Aging (NIA)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nilanjan Sarkar, David K. Wilson Professor of Engineering, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT05178992
Other Study ID Numbers:
  • 210386
  • R01AG062685
First Posted:
Jan 5, 2022
Last Update Posted:
Jan 5, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Nilanjan Sarkar, David K. Wilson Professor of Engineering, Vanderbilt University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2022